This TriMark Publications "Company Business Analysis and Segment Overview" (CBASO) is designed to provide a concise executive summary of a leading company in a particular industry and that company's applicable sector focus.

This CBASO provides a strategic analysis of the Affymetrix and its GeneChip microarray device: including its strengths, opportunities, weaknesses and threats. In the process, this CBASO takes a look at the functionality of the GeneChip, detailing its features, pricing and operator deployments.

It also looks at Affymetrix's partners and third party solutions providers.